CSL - Gross Profit On Sales

Stock Price
146.76
Daily Change
0.74 0.51%
Monthly
-18.55%
Yearly
-43.68%
Q1 Forecast
150.05

CSL reported $1.75B in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
CSL USD 1.75B 2.53B Jun/2025
Curis USD -7.72M 140K Jun/2024
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Immunic 0 0 Mar/2025
Infinity Pharmaceuticals USD 231K 59K Jun/2023
Minerva Neurosciences -4.27M 26.79M Dec/2024
Sangamo BioSciences -2.39M 1.09M Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024